Minicourse on homeostatic achievements about hormones and blood pressure: a challenge for chronobiologic engineering and computing

The authors introduce homeostatic results obtained without chronobiologic provisions and then call attention to the fact that the chronobiologic approach has already yielded, through the cooperation of engineers and computer scientists with physicians and basic medical scientists, some avenues toward the clinical evaluation of (and even assessment of the risk of developing) the condition of high blood pressure. Homeostatic results on blood pressure, the renin-angiotensin system, and the adrenal gland are discussed. The adrenergic nervous system and the atrial natriuretic factor are also discussed.<<ETX>>

[1]  F. Halberg,et al.  Differences and similarities among circadian characteristics of plasma renin activity in healthy young women in Japan and the United States. , 1980, The American journal of medicine.

[2]  R. Dluhy,et al.  DOPAMINERGIC BLOCKADE OF THE RENIN‐ANGIOTENSIN‐ALDOSTERONE SYSTEM: EFFECT OF HIGH AND LOW SODIUM INTAKES , 1983, Clinical endocrinology.

[3]  J. Ménard,et al.  Direct radioimmunoassay of human renin. , 1979, The Journal of clinical endocrinology and metabolism.

[4]  P. Weidmann,et al.  Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man. , 1986, The Journal of clinical endocrinology and metabolism.

[5]  G. Cornelissen,et al.  Important time, though not causal, relations in atrial natriuretic peptide, cortisol and renin. , 1986, Chronobiologia.

[6]  J. Seidman,et al.  Atrial natriuretic peptide transcription, secretion, and glomerular receptor activity during mineralocorticoid escape in the rat. , 1986, The Journal of clinical investigation.

[7]  J. Sowers,et al.  Effect of metoclopramide and domperidone on aldosterone, 18-hydroxycorticosterone and prolactin secretion in the rhesus monkey. , 1982, Metabolism: clinical and experimental.

[8]  C. Gomez-Sanchez Cushing's syndrome and hypertension. , 1986, Hypertension.

[9]  N. Trippodo,et al.  Natriuretic response to atrial natriuretic factor enhanced by angiotensin II and vasopressin. , 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[10]  E. Baulieu Current Approaches to Steroid Hormone-Cell Interactions , 1979 .

[11]  G. Cornelissen,et al.  Circadian rhythms of plasma renin activity and aldosterone: changes related to age, sex, recumbency and sodium restriction. Chronobiologic specification for reference values. , 1985, Chronobiology international.

[12]  L. Navar,et al.  Effects of Angiotensin on the Renal Circulation , 1974 .

[13]  J. Oates,et al.  Malignant Hypertension: Effect of Therapy on Renin and Aldosterone , 1971, Circulation research.

[14]  M. Cantin,et al.  Mechanisms of release of atrial natriuretic factor. I. Effect of several agonists and steroids on its release by atrial minces. , 1986, Biochemical and biophysical research communications.

[15]  P. Needleman,et al.  Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis. , 1985, Science.

[16]  G. Cornelissen,et al.  Effect of ageing on circadian rhythms of plasma renin and aldosterone in mesor-hypertensive women. , 1982, Maturitas.

[17]  S. Snyder,et al.  Angiotensin-converting enzyme in the testis and epididymis: differential development and pituitary regulation of isozymes. , 1985, Endocrinology.

[18]  J. Laragh,et al.  Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. , 1985, The New England journal of medicine.

[19]  G. Norbiato,et al.  Metoclopramide increases plasma aldosterone concentration in man. , 1977, The Journal of clinical endocrinology and metabolism.

[20]  S. Bloom,et al.  The plasma atrial natriuretic peptide response to treatment of acute cardiac failure, spontaneous supraventricular tachycardia and induced re-entrant tachycardia in man. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[21]  R. Luke,et al.  Reduction of toxicity of corticosteroid therapy after renal transplantation. , 1972, The American journal of medicine.

[22]  T. Strom,et al.  Comparison of Plasma Atrial Natriuretic Peptide Levels in Healthy Children from Birth to Adolescence and in Children with Cardiac Diseases1 , 1986, Pediatric Research.

[23]  R. Carey,et al.  Dopamine inhibits the aldosterone response to upright posture. , 1986, The Journal of clinical endocrinology and metabolism.

[24]  C. Edwards,et al.  IN VIVO AND IN VITRO STUDIES ON THE EFFECT OF METOCLOPRAMIDE ON ALDOSTERONE SECRETION , 1980, Clinical endocrinology.

[25]  C. Johnston,et al.  LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSION , 1979, The Lancet.

[26]  R. Cuneo,et al.  Studies on the secretion, metabolism and action of atrial natriuretic peptide in man. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[27]  R. Dluhy,et al.  β-Endorphin Stimulates Plasma Renin and Aldosterone Release in Normal Human Subjects* , 1985 .

[28]  E. Silverstein,et al.  Elevated serum angiotensin-converting enzyme in hyperthyroidism. , 1983, The American journal of medicine.

[29]  G. Cornelissen,et al.  Construction of rhythm-specified reference intervals and regions, with emphasis on 'hybrid' data, illustrated for plasma cortisol. , 1983, Chronobiologia.

[30]  K. Kangawa,et al.  Structural identification of β- and γ-human atrial natriuretic polypeptides , 1985, Nature.

[31]  H. Sekihara,et al.  Plasma levels of atrial natriuretic peptide in primary aldosteronism and essential hypertension. , 1986, The Journal of clinical endocrinology and metabolism.

[32]  H. L. Stone,et al.  The effect of metoclopramide and dopamine on plasma aldosterone concentration in normal man and rhesus monkeys (Macaca mulatta): a new model to study dopamine control of aldosterone secretion. , 1982, The Journal of clinical endocrinology and metabolism.

[33]  R. Fraser,et al.  DOPAMINE EFFECTS ON 11‐DEOXYCORTICOSTERONE CONCENTRATIONS IN PATIENTS WITH CUSHING'S SYNDROME AND IN VITRO , 1986, Clinical endocrinology.

[34]  E. H. Blaine,et al.  Synthetic Atrial Natriuretic Factor in Conscious Normotensive and Hypertensive Rats , 1985, Hypertension.

[35]  S. Ball,et al.  Diurnal change in plasma atrial natriuretic peptide concentrations. , 1987, Clinical science.

[36]  W. Samson,et al.  Atrial Natriuretic Factor Inhibits Vasotocin-Induced Water Reabsorption in the Toad Urinary Bladder , 1986, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[37]  J. Laragh,et al.  Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs. , 1986, Hypertension.

[38]  E. Slater,et al.  Pure human renin. Identification and characterization and of two major molecular weight forms. , 1981, The Journal of biological chemistry.

[39]  T. Flynn,et al.  The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. , 1983, Biochemical and biophysical research communications.

[40]  T. Eisenhauer,et al.  Detection of fluid overload by plasma concentration of human atrial natriuretic peptide (h-ANP) in patients with renal failure. , 1986, Klinische Wochenschrift.

[41]  J. Melby,et al.  Converting-enzyme inhibitor administration lowers urinary free 19-nor-deoxycorticosterone levels. , 1985, Hypertension.

[42]  J. Bauer,et al.  Hemodynamic and renal function in essential hypertension during treatment with enalapril. , 1985, The American journal of medicine.

[43]  E. Espiner,et al.  Lack of direct effect of dopamine on aldosterone secretion in vivo. , 1983, Endocrinology.

[44]  P. Erne,et al.  Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. , 1986, The New England journal of medicine.

[45]  P. Needleman,et al.  Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptide. , 1985, Science.

[46]  A. Ahlgren,et al.  Circadian systolic and diastolic hyperbaric indices of high school and college students. , 1984, Chronobiologia.

[47]  R. Nutt,et al.  Vasodilator profile of synthetic atrial natriuretic factor. , 1984, European journal of pharmacology.

[48]  M. Cantin,et al.  Distinct localization of atrial natriuretic factor and angiotensin II binding sites in the glomerulus. , 1986, The American journal of physiology.

[49]  Andrew,et al.  Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. , 1986, The Journal of clinical investigation.

[50]  W. Ganong,et al.  Extra-atrial expression of the gene for atrial natriuretic factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[51]  F. Beck,et al.  Absent aldosterone response to metoclopramide in patients with high spinal cord transection: evidence that metoclopramide stimulates aldosterone secretion through central pathways. , 1985, Life sciences.

[52]  M. Sambhi,et al.  Effect of L-dopa and bilateral nephrectomy on the aldosterone response to metoclopramide. , 1980, Life sciences.

[53]  N. Shock,et al.  Association between blood pressure and the rate of decline in renal function with age. , 1984, Kidney international.

[54]  A. Shore,et al.  EFFECTS OF CHANGES IN DIETARY SODIUM INTAKE AND SALINE INFUSION ON IMMUNOREACTIVE ATRIAL NATRIURETIC PEPTIDE IN HUMAN PLASMA , 1985, The Lancet.

[55]  G. Cornélissen,et al.  Chronobiologic blood pressure assessment with a cardiovascular summary, the sphygmochron , 1990 .

[56]  L. Resnick,et al.  Angiotensin I converting enzyme activity in hypertension. Relationship to blood pressure, renin-sodium profiles, and antihypertensive therapy. , 1985, The American journal of medicine.

[57]  S. Bloom,et al.  Diurnal rhythm in the plasma concentration of atrial natriuretic peptide. , 1986, The New England journal of medicine.

[58]  R. Carey,et al.  Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone. , 1979, The Journal of clinical investigation.

[59]  E. Bates,et al.  The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. , 1986, Circulation.

[60]  D. Ganten,et al.  Plasma atrial natriuretic peptide values in cardiac disease. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[61]  G. Cornelissen,et al.  Effect of an adrenocorticotropin analogue, ACTH 1-17, on DNA synthesis in murine metaphyseal bone. , 1985, Biochemical pharmacology.

[62]  K. Catt,et al.  Dopaminergic modulation of aldosterone secretion in the rat. , 1984, Endocrinology.

[63]  R. Carey,et al.  Possible mechanism of action of metoclopramide-induced aldosterone secretion: in vivo and in vitro studies in the sheep. , 1983, Endocrinology.

[64]  J. Funder,et al.  The etiology of a syndrome of factitious mineralocorticoid excess: a steroid-containing nasal spray. , 1979, The Journal of clinical endocrinology and metabolism.

[65]  F. Beck,et al.  Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man. , 1983, Acta endocrinologica.

[66]  B. McEwen,et al.  Adrenal steroid receptors and actions in the nervous system. , 1986, Physiological reviews.

[67]  F. Takaku,et al.  Atrial natriuretic factor in human blood. , 1985, The Journal of clinical investigation.

[68]  R. Dluhy,et al.  Dopaminergic modulation of aldosterone responsiveness to angiotensin II with changes in sodium intake. , 1983, The Journal of clinical endocrinology and metabolism.

[69]  D. Schrier,et al.  Inhibition of vascular permeability changes in rats by captopril. , 1982, The Journal of clinical investigation.

[70]  M. Littner,et al.  Circadian rhythm of plasma renin activity in older normal and essential hypertensive men: relation with inactive renin, aldosterone, cortisol and REM sleep. , 1986, Journal of hypertension.

[71]  J. O. Davis,et al.  Mechanisms regulating renin release. , 1976, Physiological reviews.

[72]  C. Saper,et al.  Atriopeptins as cardiac hormones. , 1985, Hypertension.

[73]  J. Ménard,et al.  Multiple forms of human renin. Purification and characterization. , 1979, The Journal of biological chemistry.

[74]  E. Schiffrin,et al.  Vascular and Adrenal Binding Sites for Atrial Natriuretic Factor Effects of Sodium and Hypertension , 1986 .

[75]  J. Sowers,et al.  Dopaminergic regulation of circadian rhythms of blood pressure, renin and aldosterone in essential hypertension. , 1982, Cardiovascular research.

[76]  M. Yasujima,et al.  Effects of acute water load, hypertonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans. , 1986, The Journal of clinical endocrinology and metabolism.

[77]  M. Epstein,et al.  Increases in circulating atrial natriuretic factor during immersion-induced central hypervolaemia in normal humans. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[78]  H. Gavras,et al.  Reciprocal relation between renin dependency and sodium dependency in essential hypertension. , 1976, The New England journal of medicine.

[79]  H. Yokosawa,et al.  Human renal renin. Complete purification and characterization. , 1980, The Journal of biological chemistry.

[80]  A. Gerbes,et al.  Atrial natriuretic factor in plasma of patients with arterial hypertension, heart failure or cirrhosis of the liver. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[81]  J. Sowers,et al.  Circadian blood pressure and renin, aldosterone, cortisol, and prolactin levels in hypertensive pseudohypoparathyroid patients. , 1982, The Journal of clinical endocrinology and metabolism.

[82]  E. Schiffrin,et al.  Cyclic GMP as mediator and biological marker of atrial natriuretic factor. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[83]  F. Halberg Quo vadis basic and clinical chronobiology: promise for health maintenance. , 1983, The American journal of anatomy.

[84]  B. Brenner,et al.  Biologically active atrial peptides. , 1985, The Journal of clinical investigation.

[85]  S. Tretli,et al.  ENALAPRIL, ATENOLOL, AND HYDROCHLOROTHIAZIDE IN MILD TO MODERATE HYPERTENSION A Comparative Multicentre Study in General Practice in Norway , 1986, The Lancet.

[86]  R. Horton,et al.  Role of atrial natriuretic factor in renin release. , 1986, Endocrinology.

[87]  J. Tait,et al.  The effect of serotonin and potassium on corticosterone and aldosterone production by isolated zona glomerulosa cells of the rat adrenal cortex. , 1972, Australian Journal of Experimental Biology and Medical Science.

[88]  J. Hampton,et al.  Treatment of high blood pressure: should clinical practice be based on results of clinical trials? , 1986, British medical journal.

[89]  G. Cornelissen,et al.  Circadian rhythms of plasma renin, aldosterone and cortisol on habitual and low dietary sodium intake. , 1981, Hormone research.

[90]  T. Tulassay,et al.  ATRIAL NATRIURETIC PEPTIDE IN PLASMA OF VOLUME-OVERLOADED CHILDREN WITH CHRONIC RENAL FAILURE , 1985, The Lancet.

[91]  E. Biglieri,et al.  17-hydroxylation deficiency in man. , 1966, The Journal of clinical investigation.

[92]  A. D. de Bold,et al.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. , 1981, Life sciences.

[93]  G. Lenoir,et al.  Nyctohemeral Rhythm of Plasma Renin Activity and Plasma Aldosterone in Children , 1982, Pediatric Research.

[94]  R. Gerzer,et al.  The increase of cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclase , 1985, FEBS letters.

[95]  H. Imura,et al.  Significance of α‐Human Atrial Natriuretic Polypeptide as a Hormone in Humans , 1986 .

[96]  D. Wilson,et al.  Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. , 1986, The American journal of physiology.

[97]  D. Lykken,et al.  Rhythmometry reveals heritability of circadian characteristics of heart rate of human twins reared apart. , 1984, Cardiologia.

[98]  G. Nyberg,et al.  Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. , 1986, British medical journal.

[99]  R. Nutt,et al.  Specific membrane receptors for atrial natriuretic factor in renal and vascular tissues. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[100]  J. Pfeilschifter,et al.  Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[101]  P. Weidmann,et al.  Effects of posture and ageing on circulating atrial natriuretic peptide levels in man. , 1987, Journal of hypertension.

[102]  J. Biollaz,et al.  Four‐Hour Infusions of Synthetic Atrial Natriuretic Peptide in Normal Volunteers , 1986, Hypertension.

[103]  Y. Kawano,et al.  The renin-angiotensin-aldosterone system and circadian rhythm of urine variables in normotensive and hypertensive subjects. , 1984, Japanese circulation journal.

[104]  S. Bloom,et al.  Atrial natriuretic peptide: physiological release associated with natriuresis during water immersion in man. , 1986, Clinical science.

[105]  R. Kageyama,et al.  Cloning and sequence analysis of cDNA for rat angiotensinogen. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[106]  A. Shulkes,et al.  Effect of intravenous infusion of corticosteroids on blood pressure, electrolytes, and water metabolism in sheep. , 1975, The American journal of physiology.

[107]  J. Melby,et al.  Adrenocortical Factors in Hypertension , 1985, Journal of clinical pharmacology.

[108]  R. Carey,et al.  Control of renal function by intrarenal angiotensin II. , 1983, Endocrinology.

[109]  [Circadian rhythm of plasma renin activity]. , 1979, Minerva cardioangiologica.

[110]  J. Boger,et al.  Comparison of Renin and Converting Enzyme Inhibition in Sodium‐Deficient Dogs , 1985, Hypertension.

[111]  G. Vinson,et al.  Dopaminergic control of aldosterone: Modulation of the response of rat adrenal zona glomerulosa cells to α-MSH by pretreatment with bromocriptine or metoclopramide , 1982, Steroids.

[112]  R. Gordon,et al.  PLASMA LEVELS OF ATRIAL NATRIURETIC PEPTIDE IN MAN IN PRIMARY ALDOSTERONISM, IN GORDON'S SYNDROME AND IN BARTTER'S SYNDROME , 1986, Clinical and experimental pharmacology & physiology.

[113]  W. Roberts,et al.  The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: A study of 36 necropsy patients , 1975 .

[114]  F. Halberg,et al.  24-Hour Rhythms at Several Levels of Integration in Mice on Different Lighting Regimens.∗ , 1958, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[115]  A. Bongiovanni,et al.  Plasma and urinary corticosteroids in the hypertensive form of congenital adrenal hyperplasia. , 1956, The Journal of biological chemistry.

[116]  R. Sothern,et al.  Ageing and circadian rhythm of plasma renin and aldosterone. , 1981, Maturitas.

[117]  F. Halberg,et al.  Comparison of circadian rhythms of the renin-angiotensin-aldosterone system and electrolytes in clinically healthy young women in Fukuoka (Japan) and Minnesota (USA). , 1983, Acta endocrinologica.

[118]  P. Weidmann,et al.  Blood levels and renal effects of atrial natriuretic peptide in normal man. , 1986, The Journal of clinical investigation.

[119]  J. Agarwal,et al.  Blood Flow and Tissue Space of the Left Coronary Artery in Man , 1970, Circulation research.

[120]  F. Beck,et al.  Dopaminergic modulation of corticosteroid responses to angiotensin II in man. , 1983, Clinical and experimental hypertension. Part A, Theory and practice.

[121]  F. Halberg,et al.  Chronobiologic assessment of human blood pressure variation in health and disease , 1984 .

[122]  M. Cantin,et al.  Specific receptor-mediated inhibition by synthetic atrial natriuretic factor of hormone-stimulated steroidogenesis in cultured bovine adrenal cells. , 1984, Endocrinology.

[123]  B. Brenner,et al.  Physiologic regulation of atrial natriuretic peptide receptors in rat renal glomeruli. , 1985, The Journal of clinical investigation.

[124]  K. Kangawa,et al.  α‐HUMAN ATRIAL NATRIURETIC POLYPEPTIDE REDUCES THE PLASMA ARGININE VASOPRESSIN CONCENTRATION IN HUMAN SUBJECTS , 1986, Clinical endocrinology.

[125]  T. Tulassay,et al.  Atrial natriuretic peptide and other vasoactive hormones in nephrotic syndrome. , 1987, Kidney international.

[126]  F Halberg,et al.  Cardiovascular reference data base for recognizing circadian mesor- and amplitude-hypertension in apparently healthy men. , 1984, Chronobiologia.

[127]  K. Catt,et al.  Hormonal regulation of peptide receptors and target cell responses , 1979, Nature.

[128]  H. Yoshimi,et al.  Specific receptors for atrial natriuretic factor (ANF) in cultured vascular smooth muscle cells of rat aorta. , 1984, Biochemical and biophysical research communications.

[129]  C. Gomez-Sanchez,et al.  Aldosterone suppression with dopamine infusion in low-renin hypertension. , 1983, The Journal of clinical investigation.

[130]  I. Tikkanen,et al.  PLASMA ATRIAL NATRIURETIC PEPTIDE IN CARDIAC DISEASE AND DURING INFUSION IN HEALTHY VOLUNTEERS , 1985, The Lancet.

[131]  O. Carretero,et al.  Effect of glandular kallikrein on renin release in isolated rat glomeruli. , 1985, Hypertension.

[132]  J. Onrot,et al.  Sodium Loading and Posture Modulate Human Atrial Natriuretic Factor Plasma Levels , 1986, Hypertension.

[133]  T. Inoue,et al.  Plasma levels of atrial natriuretic peptide in patients with chronic renal failure. , 1986, The Journal of clinical endocrinology and metabolism.

[134]  P. Needleman,et al.  Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis. , 1986, The New England journal of medicine.

[135]  F. Veglio,et al.  Circadian rhythm of the angiotensin converting enzyme (ACE) activity in serum of healthy adult subjects. , 1987, Chronobiologia.

[136]  H. Gavras,et al.  Blood Pressure Response to Central and /or Peripheral Inhibition of Phenylethanolamine N‐Methyltransferase in Normotensive and Hypertensive Rats , 1981, Circulation research.

[137]  A. Shore,et al.  ATRIAL NATRIURETIC PEPTIDE LEVELS IN TREATED CONGESTIVE HEART FAILURE , 1986, The Lancet.

[138]  T. Tunny,et al.  PLASMA ATRIAL NATRIURETIC PEPTIDE IN PRIMARY ALDOSTERONISM (BEFORE AND AFTER TREATMENT) AND IN BARTTER'S AND GORDON'S SYNDROMES , 1986, The Lancet.

[139]  E. Gomez-Sanchez Intracerebroventricular infusion of aldosterone induces hypertension in rats. , 1986, Endocrinology.

[140]  Y. Wakiya,et al.  Relationship between plasma atrial natriuretic peptide levels and atrial pressure in man. , 1986, The Journal of clinical endocrinology and metabolism.

[141]  P. Weidmann,et al.  Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man. , 1986, Journal of Clinical Endocrinology and Metabolism.

[142]  K. Berecek,et al.  Whole Body Vascular Reactivity during the Development of Deoxycorticosterone Acetate Hypertension in the Pig , 1978, Circulation research.

[143]  T. Inagami,et al.  Synthetic rat atrial natriuretic factor inhibits in vitro and in vivo renin secretion in rats. , 1985, Endocrinology.

[144]  P. Cugini,et al.  Rhythm characteristics of plasma renin, aldosterone and Cortisol in five subtypes of mesor-hypertension , 1980, Journal of endocrinological investigation.

[145]  A. Butkus,et al.  THE AFFINITY OF 17α‐HYDROXYPROGESTERONE AND 17α, 20α‐DIHYDROXYPROGESTERONE FOR CLASSICAL MINERALOCORTICOID OR GLUCOCORTICOID RECEPTORS , 1982 .

[146]  R. Cohn,et al.  Alternate-day prednisone therapy after renal transplantation. , 1970, Lancet.

[147]  H. Parving,et al.  Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. , 1986, British medical journal.

[148]  W. Forssmann,et al.  Cardiac hormones. I. Review on the morphology, biochemistry, and molecular biology of the endocrine heart , 1986, European journal of clinical investigation.

[149]  V. Fang,et al.  A serotonergic mechanism of the prolactin-stimulating action of metoclopramide. , 1981, Endocrinology.

[150]  A. D. Bold,et al.  Atrial natriuretic factor: a hormone produced by the heart. , 1985, Science.

[151]  K. Kangawa,et al.  High plasma concentrations of human atrial natriuretic polypeptide in aged men. , 1987, The Journal of clinical endocrinology and metabolism.

[152]  J. Sowers,et al.  Effect of prostaglandin inhibition on the prolactin, renin, and aldosterone responses to dopamine antagonism. , 1982, Metabolism: clinical and experimental.

[153]  M. Cantin,et al.  Gluco- and mineralocorticoids may regulate the natriuretic effect and the synthesis and release of atrial natriuretic factor by the rat atria in vivo. , 1985, Biochemical and biophysical research communications.

[154]  D. Streeten,et al.  Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;. , 1975, The New England journal of medicine.

[155]  A. Veress,et al.  Cellular mechanism of release of atrial natriuretic factor. , 1984, Biochemical and biophysical research communications.

[156]  D. Duval,et al.  Cardiac glucocorticoid receptors: the binding of tritiated dexamethasone in rat and dog heart. , 1973, Endocrinology.

[157]  A. Richards,et al.  Effects of alpha-human atrial natriuretic peptide in essential hypertension. , 1985, Hypertension.

[158]  G. Cornelissen,et al.  Instrumentation for Human Blood Pressure Rhythm Assessment by Self-Measurement , 1987 .

[159]  G. Williams,et al.  Metoclopramide inhibits aldosterone biosynthesis in vitro. , 1982, Endocrinology.

[160]  A. J. Bold Heart atria granularity effects of changes in water-electrolyte balance. , 1979 .

[161]  P. Weidmann,et al.  Plasma arginine-vasopressin levels during infusion of synthetic atrial natriuretic peptide on different sodium intakes in man. , 1986, Journal of hypertension.

[162]  R. Buñag Circulatory Effects of Angiotensin , 1974 .

[163]  C. Simon,et al.  Nocturnal fluctuations of plasma atrial natriuretic peptide in normotensive and hypertensive men. , 1988, Life sciences.

[164]  J. Laragh,et al.  Prorenin and other large molecular weight forms of renin. , 1980, Endocrine reviews.

[165]  P. Weidmann,et al.  Increase in Circulating Insulin Induced by Atrial Natriuretic Peptide in Normal Humans , 1986, Journal of cardiovascular pharmacology.

[166]  M. Cantin,et al.  Synthetic Atrial Natriuretic Factor Induces Release (Possibly Receptor-Mediated) of Vasopressin from Rat Posterior Pituitary , 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[167]  G. Cornelissen,et al.  Circadian characteristics of urinary melatonin from clinically healthy young women at different civilization disease risks. , 2009, Acta medica Scandinavica.

[168]  D. Jacobowitz,et al.  The nyctohemeral rhythm of plasma prolactin: effects of ganglionectomy, pinealectomy, constant light, constant darkness or 6-OH-dopamine administration. , 1975, Endocrinology.

[169]  D. Ganten,et al.  Atrial natriuretic factor—a circulating hormone stimulated by volume loading , 1985, Nature.

[170]  M. Furuya,et al.  Localization of binding sites for alpha-rat atrial natriuretic polypeptide in rat kidney. , 1986, The American journal of physiology.

[171]  R. Carey,et al.  Dopaminergic suppression of angiotensin II-induced aldosterone secretion in man: differential responses during sodium loading and depletion. , 1984, Metabolism: clinical and experimental.

[172]  C. Simon,et al.  Night-day differences in the ultradian rhythmicity of plasma renin activity. , 1987, Life sciences.

[173]  H. Kunita,et al.  The effects of dietary sodium on the diurnal activity of the renin-angiotensin-aldosterone system and the excretion of urinary electrolytes. , 1976, The Journal of clinical endocrinology and metabolism.

[174]  M. Currie,et al.  Evidence for α-1 adrenergic receptor regulation of atriopeptin release from the isolated rat heart , 1986 .

[175]  N. Hollenberg,et al.  Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives. , 1985, The Journal of clinical investigation.

[176]  W. Samson,et al.  Atrial natriuretic factor inhibits dehydration- and angiotensin II-induced water intake in the conscious, unrestrained rat. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[177]  K. Kangawa,et al.  Inhibition of aldosterone production by alpha-human atrial natriuretic polypeptide is associated with an increase in cGMP production. , 1985, Biochemical and biophysical research communications.

[178]  B. Brenner,et al.  Atrial peptides inhibit oxygen consumption in kidney medullary collecting duct cells. , 1986, The American journal of physiology.

[179]  A. Ganguly,et al.  Metoclopramide Fails to Stimulate Aldosterone Secretion and Inhibits Serotonin-Mediated Aldosterone Secretion in the Rat , 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[180]  L. Krakoff,et al.  Hormonal Control of Plasma Renin Substrate (Angiotensinogen) , 1977, Circulation research.

[181]  J. Winnacker,et al.  Low renin, "normal" aldosterone and hypertension: circadian rhythm of renin, aldosterone, cortisol and growth hormone. , 1974, The Journal of clinical endocrinology and metabolism.

[182]  M. Schaller,et al.  Dopaminergic Control of Aldosterone Secretion in Hypertensive Patients Chronically Treated with an Angiotensin Converting Enzyme Inhibitor , 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[183]  C. Edwards,et al.  INHIBITION OF THE PLASMA-ALDOSTERONE RESPONSE TO FRUSEMIDE BY BROMOCRIPTINE , 1975, The Lancet.

[184]  T. Saruta,et al.  EFFECT OF METOCLOPRAMIDE ON THE SECRETION OF ALDOSTERONE AND OTHER ADRENOCORTICAL STEROIDS , 1983, Clinical endocrinology.

[185]  D. Straughan,et al.  Influence of 5‐hydroxytryptamine uptake on the apparent 5‐hydroxytryptamine antagonist potency of metoclopramide in the rat isolated superior cervical ganglion , 1987, British journal of pharmacology.

[186]  M. Cantin,et al.  Mechanisms of release of atrial natriuretic factor. II. Effect of chronic administration of α- and β-adrenergic and cholinergic agonists on plasma and atrial ANF in the rat , 1986 .

[187]  J. Baxter,et al.  Atrial natriuretic peptide mRNA is regulated by glucocorticoids in vivo. , 1986, Biochemical and biophysical research communications.

[188]  R. Gordon,et al.  Influence of sodium balance on ACTH/adrenal corticosteroid dose-response curves in the dog. , 1980, The American journal of physiology.

[189]  D. Denton,et al.  Dopaminergic modulation of aldosterone secretion? , 1981, The Journal of endocrinology.

[190]  A. Shore,et al.  RAISED CIRCULATING LEVELS OF ATRIAL NATRIURETIC PEPTIDES IN ESSENTIAL HYPERTENSION , 1986, The Lancet.

[191]  R. Carey,et al.  Dopamine modulates sodium-dependent aldosterone responses to angiotensin II in humans. , 1984, Hypertension.

[192]  E. Haus,et al.  Rhythm-adjusted age effects in a concomitant study of twelve hormones in blood plasma of women. , 1980, Journal of gerontology.

[193]  R. Re Cellular biology of the renin-angiotensin systems. , 1984, Archives of internal medicine.

[194]  J. Habener,et al.  Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. , 1986, The Journal of clinical investigation.

[195]  J. Connell,et al.  Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia? , 1986, Hypertension.

[196]  W. Samson Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release. , 1985, Neuroendocrinology.

[197]  M. Currie,et al.  Purification and sequence analysis of bioactive atrial peptides (atriopeptins). , 1984, Science.

[198]  R. Lorenz,et al.  Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism. , 1985, Clinical science.

[199]  G. Cornelissen,et al.  The Chronobiologic Pilot Study with Special Reference to Cancer Research is Chronobiology or, rather, its Neglect Wasteful? , 1989 .

[200]  R. Good,et al.  Some Aspects of the Cardiovascular and Renal Circadian Systems , 1966, Circulation.

[201]  B. E. Watkins,et al.  Circadian Changes in Plasma Renin Activity and Plasma Aldosterone Concentrationin Two‐Kidney Hypertensive Rats , 1979, Hypertension.

[202]  T. Inagami,et al.  Immunohistological evidence for renin in human endocrine tissues. , 1985, The Journal of clinical endocrinology and metabolism.

[203]  T. Goodfriend,et al.  Inhibition of aldosterone synthesis by atrial natriuretic factor. , 1986, Federation proceedings.

[204]  J. Grünfeld,et al.  Effects of antiglucocorticoids on glucocorticoid hypertension in the rat. , 1985, Hypertension.

[205]  H. Wernze,et al.  Atrial natriuretic peptide in hepatic cirrhosis: relation to stage of disease, sympathoadrenal system and renin-aldosterone axis. , 1986, Klinische Wochenschrift.

[206]  J. Reid,et al.  Central and Peripheral Adrenergic Mechanisms in the Development of Deoxycorticosterone‐Saline Hypertension in Rats , 1975, Circulation research.

[207]  J. Conn Hypertension, the potassium ion and impaired carbohydrate tolerance. , 1965, The New England journal of medicine.

[208]  S. Atlas Atrial natriuretic factor: a new hormone of cardiac origin. , 1986, Recent progress in hormone research.

[209]  J. Sowers,et al.  Dopaminergic modulation of aldosterone secretion in man is unaffected by glucocorticoids and angiotensin blockade. , 1981, The Journal of clinical endocrinology and metabolism.

[210]  F. Katz,et al.  Diurnal variation of plasma aldosterone, cortisol and renin activity in supine man. , 1975, The Journal of clinical endocrinology and metabolism.

[211]  G. Norbiato,et al.  Metoclopramide increases vasopressin secretion. , 1986, The Journal of clinical endocrinology and metabolism.

[212]  K. Kangawa,et al.  Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP) , 1984 .

[213]  I. Miyamori,et al.  Human atrial natriuretic polypeptide during escape from mineralocorticoid excess in man. , 1987, Clinical science.